{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:08:37Z","timestamp":1793203717505,"version":"4.5.0"},"reference-count":152,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01 HL127071"],"award-info":[{"award-number":["NIH R01 HL127071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26 million people suffering from CKD in the United States alone. More patients with CKD die of cardiovascular complications than progress to dialysis. Over 80% of CKD patients have hypertension, which is associated with increased risk of cardiovascular morbidity and mortality. Another common, perhaps underappreciated, feature of CKD is an overactive sympathetic nervous system. This elevation in sympathetic nerve activity (SNA) not only contributes to hypertension but also plays a detrimental role in the progression of CKD independent of any increase in blood pressure. Indeed, high SNA is associated with poor prognosis and increased cardiovascular morbidity and mortality independent of its effect on blood pressure. This brief review will discuss some of the consequences of sympathetic overactivity and highlight some of the potential pathways contributing to chronically elevated SNA in CKD. Mechanisms leading to chronic sympathoexcitation in CKD are complex, multifactorial and to date, not completely understood. Identification of the mechanisms and\/or signals leading to sympathetic overactivity in CKD are crucial for development of effective therapeutic targets to reduce the increased cardiovascular risk in this patient group.<\/jats:p>","DOI":"10.3390\/ijms18081682","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T10:05:25Z","timestamp":1501668325000},"page":"1682","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms"],"prefix":"10.3390","volume":"18","author":[{"given":"Jasdeep","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fadel","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Saran, R., Li, Y., Robinson, B., Abbott, K.C., Agodoa, L.Y., Ayanian, J., Bragg-Gresham, J., Balkrishnan, R., Chen, J.L., and Cope, E. (2016). US Renal Data System 2015 Annual Data Report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis.","DOI":"10.1053\/j.ajkd.2015.05.001"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1681\/ASN.2012040392","article-title":"Medical costs of CKD in the Medicare population","volume":"24","author":"Honeycutt","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/j.ajkd.2011.02.376","article-title":"Sudden cardiac death in hemodialysis patients: An in-depth review","volume":"57","author":"Green","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2015.2","article-title":"United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease","volume":"5","author":"Collins","year":"2015","journal-title":"Kidney Int. Suppl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease","volume":"15","author":"Mallamaci","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1152\/japplphysiol.90849.2008","article-title":"Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease","volume":"105","author":"Park","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure","volume":"57","author":"Grassi","year":"2011","journal-title":"Hypertension"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.2215\/CJN.06970711","article-title":"Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease","volume":"6","author":"Grassi","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.ASN.0000045049.72965.B7","article-title":"Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure","volume":"14","author":"Klein","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archinte.1985.00360060069008","article-title":"Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Effect of hemodialysis","volume":"145","author":"Elias","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1097\/01.ASN.0000098687.01005.A5","article-title":"Sympathetic nerve activity is inappropriately increased in chronic renal disease","volume":"14","author":"Klein","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension","volume":"12","author":"Klein","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","article-title":"Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats","volume":"11","author":"Amann","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.autneu.2009.02.003","article-title":"Central sympathetic overactivity: Maladies and mechanisms","volume":"148","author":"Fisher","year":"2009","journal-title":"Auton. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11906-011-0200-4","article-title":"Sympathetic mechanisms, organ damage, and antihypertensive treatment","volume":"13","author":"Grassi","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_23","first-page":"208","article-title":"The sympathetic system in hypertension. State-of-the-art review","volume":"4","author":"Abboud","year":"1982","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjhyper.2003.10.010","article-title":"Relationship between central sympathetic activity and stages of human hypertension","volume":"17","author":"Smith","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.HYP.31.1.68","article-title":"Baroreflex control of sympathetic nerve activity in essential and secondary hypertension","volume":"31","author":"Grassi","year":"1998","journal-title":"Hypertension"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/ajkd.1998.v32.pm9820463","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?","volume":"32","author":"Levey","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archinte.161.9.1207","article-title":"Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988\u20131994)","volume":"161","author":"Coresh","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/cvr\/cvn022","article-title":"Hypertension and microvascular remodelling","volume":"78","author":"Feihl","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1152\/physrev.1982.62.2.347","article-title":"Physiological aspects of primary hypertension","volume":"62","author":"Folkow","year":"1982","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Katholi, R.E., and Couri, D.M. (2011). Left ventricular hypertrophy: Major risk factor in patients with hypertension: Update and practical clinical applications. Int. J. Hypertens.","DOI":"10.4061\/2011\/495349"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI111023","article-title":"Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response","volume":"72","author":"Simpson","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_32","first-page":"H31","article-title":"Norepinephrine increases \u03b2-receptors and adenylate cyclase in canine myocardium","volume":"246","author":"Raum","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.64.1.75","article-title":"Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog","volume":"64","author":"Laks","year":"1973","journal-title":"Chest"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.RES.37.1.14","article-title":"Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery","volume":"37","author":"Bevan","year":"1975","journal-title":"Circ. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.HYP.6.6_Pt_2.III19","article-title":"Trophic effects of peripheral adrenergic nerves on vascular structure","volume":"6","author":"Bevan","year":"1984","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/ajpheart.00879.2012","article-title":"Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure","volume":"304","author":"Coutsos","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.hrthm.2010.06.003","article-title":"Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis","volume":"7","author":"Volders","year":"2010","journal-title":"Heart Rhythm"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00041552-200203000-00011","article-title":"Sympathetic nervous system and the kidney in hypertension","volume":"11","author":"DiBona","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.111.064097","article-title":"Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation","volume":"125","author":"Rafiq","year":"2012","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.HYP.21.5.618","article-title":"Reflex sympathetic activation induces acute insulin resistance in the human forearm","volume":"21","author":"Jamerson","year":"1993","journal-title":"Hypertension"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R1181","DOI":"10.1152\/ajpregu.90333.2008","article-title":"Neurogenic-nitric oxide interactions affecting brachial artery mechanics in humans: Roles of vessel distensibility vs. diameter","volume":"295","author":"Salzer","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_42","first-page":"H1368","article-title":"Sympathetic activation decreases medium-sized arterial compliance in humans","volume":"267","author":"Boutouyrie","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00004872-199917080-00011","article-title":"Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects","volume":"17","author":"Failla","year":"1999","journal-title":"J. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1152\/ajpheart.00240.2006","article-title":"Sympathetic nervous system contributes to the age-related impairment of flow-mediated dilation of the superficial femoral artery","volume":"291","author":"Thijssen","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0735-1097(01)01786-7","article-title":"Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation","volume":"39","author":"Hijmering","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1152\/ajpheart.01240.2004","article-title":"Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients","volume":"289","author":"Santos","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","first-page":"96","article-title":"Using ethological principles to study psychosocial influences on coronary atherosclerosis in monkeys","volume":"640","author":"Kaplan","year":"1997","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.6836311","article-title":"Social stress and atherosclerosis in normocholesterolemic monkeys","volume":"220","author":"Kaplan","year":"1983","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1681\/ASN.V123602","article-title":"Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: Novel approach to prevent progression of diabetic nephropathy?","volume":"12","author":"Strojek","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2016.08.032","article-title":"Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease","volume":"253","author":"Anguiano","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bmj.4.5842.694","article-title":"Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure","volume":"4","author":"Medina","year":"1972","journal-title":"Br. Med. J."},{"key":"ref_52","first-page":"431","article-title":"Role of the renin-angiotensin-aldosterone system in the progression of renal disease: A critical review","volume":"17","author":"Ibrahim","year":"1997","journal-title":"Semin. Nephrol."},{"key":"ref_53","first-page":"E763","article-title":"Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure","volume":"262","author":"Reid","year":"1992","journal-title":"Am. J. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/HJH.0b013e32832b521b","article-title":"Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?","volume":"27","author":"Siddiqi","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1152\/japplphysiol.00261.2001","article-title":"Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats","volume":"92","author":"Hu","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"ref_56","first-page":"977","article-title":"Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats","volume":"260","author":"Muratani","year":"1991","journal-title":"Am. J. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)00861-5","article-title":"Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit","volume":"772","author":"Hirooka","year":"1997","journal-title":"Brain Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/14703203010020012101","article-title":"Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge","volume":"2","author":"Allen","year":"2001","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0361-9230(98)00039-2","article-title":"Angiotensin receptors in the nervous system","volume":"47","author":"Allen","year":"1998","journal-title":"Brain Res. Bull."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1152\/ajpregu.00190.2003","article-title":"Physiological genomic analysis of the brain renin-angiotensin system","volume":"285","author":"Davisson","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.25.4.878","article-title":"Renal afferent denervation prevents hypertension in rats with chronic renal failure","volume":"25","author":"Campese","year":"1995","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0895-7061(02)02959-X","article-title":"Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity","volume":"15","author":"Ye","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1997.103","article-title":"Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure","volume":"51","author":"Ye","year":"1997","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.HYP.0000231307.69761.2e","article-title":"Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension","volume":"48","author":"Ye","year":"2006","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00004872-198402040-00005","article-title":"Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog","volume":"2","author":"Katholi","year":"1984","journal-title":"J. Hypertens."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1838(81)90066-7","article-title":"Renal chemoreceptors","volume":"3","author":"Recordati","year":"1981","journal-title":"J. Auton. Nerv. Syst."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","article-title":"Adenosine and kidney function","volume":"86","author":"Vallon","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ndt\/gft083","article-title":"Renalase in hypertension and kidney disease","volume":"29","author":"Desir","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI24066","article-title":"Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure","volume":"115","author":"Xu","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MNH.0b013e3282f521ba","article-title":"Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease","volume":"17","author":"Desir","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1161\/CIRCULATIONAHA.107.732032","article-title":"Catecholamines regulate the activity, secretion, and synthesis of renalase","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-201X.2003.01182.x","article-title":"From molecules to mammals: What\u2019s NOS got to do with it?","volume":"179","author":"Mungrue","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.RES.70.3.607","article-title":"NG-methyl-l-arginine, an inhibitor of l-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?","volume":"70","author":"Sakuma","year":"1992","journal-title":"Circ. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.30.1.64","article-title":"The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-l-arginine methyl ester","volume":"30","author":"Sander","year":"1997","journal-title":"Hypertension"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.HYP.33.4.937","article-title":"A large blood pressure-raising effect of nitric oxide synthase inhibition in humans","volume":"33","author":"Sander","year":"1999","journal-title":"Hypertension"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/clinchem\/44.8.1809","article-title":"Role of nitric oxide in cardiovascular disease: Focus on the endothelium","volume":"44","author":"Cannon","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.med.48.1.489","article-title":"Nitric oxide synthase: Role in the genesis of vascular disease","volume":"48","author":"Cooke","year":"1997","journal-title":"Annu. Rev. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3940(91)90430-2","article-title":"Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat","volume":"132","author":"Shapoval","year":"1991","journal-title":"Neurosci. Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.RES.72.3.511","article-title":"Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits","volume":"72","author":"Harada","year":"1993","journal-title":"Circ. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.75.1.70","article-title":"Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices","volume":"75","author":"Tagawa","year":"1994","journal-title":"Circ. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3565(25)10757-X","article-title":"A central nervous system action of nitric oxide in blood pressure regulation","volume":"262","author":"Togashi","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/hyp.38.4.896","article-title":"Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release","volume":"38","author":"Kishi","year":"2001","journal-title":"Hypertension"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/hy0202.102701","article-title":"Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats","volume":"39","author":"Kishi","year":"2002","journal-title":"Hypertension"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.HYP.21.4.476","article-title":"Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats","volume":"21","author":"Kumagai","year":"1993","journal-title":"Hypertension"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.24.4.439","article-title":"Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?","volume":"24","author":"Hansen","year":"1994","journal-title":"Hypertension"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"R726","DOI":"10.1152\/ajpregu.00768.2004","article-title":"l-NAME and ADMA-induced sympathetic neural activation in conscious rats","volume":"290","author":"Augustyniak","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1113\/jphysiol.2009.177204","article-title":"Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans","volume":"587","author":"Young","year":"2009","journal-title":"J. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1046\/j.1523-1755.2001.0590041466.x","article-title":"Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease","volume":"59","author":"Xiao","year":"2001","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1440-1797.2007.00840.x","article-title":"Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease","volume":"12","author":"Ueda","year":"2007","journal-title":"Nephrology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.hjh.0000217839.26971.8d","article-title":"Asymmetric dimethylarginine (ADMA): A cardiovascular and renal risk factor on the move","volume":"24","author":"Zoccali","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2215\/CJN.06671208","article-title":"Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease","volume":"4","author":"Young","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainres.2016.07.026","article-title":"The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and l-arginine with the human blood-brain barrier in vitro","volume":"1648","author":"Watson","year":"2016","journal-title":"Brain Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","article-title":"Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway","volume":"24","author":"Vallance","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH\/ADMA\/NOS pathway","volume":"4","author":"Tran","year":"2003","journal-title":"Atheroscler. Suppl."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ndt\/gfx050","article-title":"Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction","volume":"32","author":"Lin","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/ndt\/gfq547","article-title":"Decreased plasma level of vitamin C in chronic kidney disease: Comparison between diabetic and non-diabetic patients","volume":"26","author":"Takahashi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"R818","DOI":"10.1152\/ajpregu.00426.2010","article-title":"Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension","volume":"300","author":"Hirooka","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ajh.2009.17","article-title":"Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension","volume":"22","author":"Nishi","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/HJH.0b013e32834e1df4","article-title":"Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats","volume":"30","author":"Nishihara","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/01.CIR.0000128695.49900.12","article-title":"Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats","volume":"109","author":"Kishi","year":"2004","journal-title":"Circulation"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/ajpheart.00619.2003","article-title":"Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity","volume":"287","author":"Campese","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.HYP.0000179088.57586.26","article-title":"Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity","volume":"46","author":"Campese","year":"2005","journal-title":"Hypertension"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.RES.0000185804.79157.C0","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla","volume":"97","author":"Chan","year":"2005","journal-title":"Circ. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"R311","DOI":"10.1152\/ajpregu.00246.2010","article-title":"Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: Role of superoxide anion","volume":"300","author":"Patel","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.RES.0000043501.47934.FA","article-title":"Superoxide mediates the actions of angiotensin II in the central nervous system","volume":"91","author":"Zimmerman","year":"2002","journal-title":"Circ. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00424-008-0627-x","article-title":"Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats","volume":"458","author":"Shi","year":"2009","journal-title":"Pflug. Arch."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/HJH.0b013e3283200442","article-title":"Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats","volume":"27","author":"Wei","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","article-title":"Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase","volume":"99","author":"Ito","year":"1999","journal-title":"Circulation"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1388-9842(03)00163-6","article-title":"Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)","volume":"5","author":"Cohn","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00544037","article-title":"Crossover comparison of moxonidine and clonidine in mild to moderate hypertension","volume":"27","author":"Planitz","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/01.CIR.0000014212.04920.62","article-title":"Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure","volume":"105","author":"Swedberg","year":"2002","journal-title":"Circulation"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.105.552174","article-title":"Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: Roles of angiotensin II type 1 receptors and NAD(P)H oxidase","volume":"112","author":"Gao","year":"2005","journal-title":"Circulation"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/jpet.107.136028","article-title":"Simvastatin inhibits central sympathetic outflow in heart failure by a nitric-oxide synthase mechanism","volume":"326","author":"Gao","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1152\/ajpheart.00289.2012","article-title":"Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure","volume":"303","author":"Deo","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10286-015-0274-1","article-title":"The effect of statins on sympathetic activity: A meta-analysis","volume":"25","author":"Lewandowski","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1097\/HJH.0b013e32834ae3c7","article-title":"Atorvastatin reduces sympathetic activity in patients with chronic kidney disease","volume":"29","author":"Siddiqi","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacl.2017.01.001","article-title":"Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia","volume":"11","author":"Chung","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2215\/CJN.07460714","article-title":"Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis","volume":"10","author":"Major","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Messow, C.M., and Isles, C. (2017). Meta-analysis of statins in chronic kidney disease: Who benefits?. QJM.","DOI":"10.1093\/qjmed\/hcx040"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3945\/ajcn.112.035022","article-title":"Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients","volume":"96","author":"Bruno","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2710.2010.01205.x","article-title":"High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure","volume":"36","author":"Gomes","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ndt\/gfq412","article-title":"Vitamin C supplementation in kidney failure: Effect on uraemic symptoms","volume":"26","author":"Singer","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/rej.2013.1434","article-title":"Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes","volume":"16","author":"Tahara","year":"2013","journal-title":"Rejuvenation Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1291\/hypres.28.255","article-title":"Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats","volume":"28","author":"Wakino","year":"2005","journal-title":"Hypertens Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The symplicity HTN-2 trial): A randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"H2302","DOI":"10.1152\/ajpheart.01029.2002","article-title":"Renal denervation chronically lowers arterial pressure independent of dietary sodium intake in normal rats","volume":"284","author":"Jacob","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1440-1681.2007.04754.x","article-title":"Early renal denervation prevents development of hypertension in growth-restricted offspring","volume":"34","author":"Ojeda","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pcad.2009.09.003","article-title":"The role of renal sympathetic nerves in hypertension: Has percutaneous renal denervation refocused attention on their clinical significance?","volume":"52","author":"Katholi","year":"2009","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1440-1681.2006.04514.x","article-title":"Renal denervation attenuates long-term hypertensive effects of Angiotensin II in the rat","volume":"33","author":"Hendel","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.0000253507.56499.bb","article-title":"Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure","volume":"49","author":"Lohmeier","year":"2007","journal-title":"Hypertension"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD","volume":"23","author":"Hering","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/15701611113119990143","article-title":"Renal nerve ablation for hypertensive patients with chronic kidney disease","volume":"12","author":"Papademetriou","year":"2014","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3181\/0802-RM-54","article-title":"Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease","volume":"233","author":"Gattone","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/eurheartj\/eht200","article-title":"Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension","volume":"34","author":"Kiuchi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ijcard.2013.01.218","article-title":"Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease","volume":"168","author":"Schlaich","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/ajpheart.00372.2010","article-title":"Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex","volume":"299","author":"Lohmeier","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","article-title":"Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients","volume":"55","author":"Heusser","year":"2010","journal-title":"Hypertension"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: Results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1682\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:44:58Z","timestamp":1760208298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":152,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"alternative-id":["ijms18081682"],"URL":"https:\/\/doi.org\/10.3390\/ijms18081682","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}